<i>FGR41</i> overexpression does not impact fungal burden 4 days post infection. by Andrew S. Wagner (11331477)

Subjects:

Proposed model for calcineurin-regulated ß(1,3)-glucan exposure. by Andrew S. Wagner (11331477)

Subjects:

Raw values associated with each graph in this study. by Andrew S. Wagner (11331477)

Subjects:

Loss of <i>FGR41</i> or <i>CWP419</i> does not attenuate fungal growth <i>in vitro</i>. by Andrew S. Wagner (11331477)

Subjects:

Characterization of serum cytokines during systemic infection with an <i>fgr41Δ/Δ</i> mutant. by Andrew S. Wagner (11331477)

Subjects:

Overexpression of calcineurin effector genes does not restore calcium-induced masking in a <i>crz1Δ/Δ</i> mutant. by Andrew S. Wagner (11331477)

Subjects:

Key cell wall proteins mediate ß(1,3)-glucan exposure in <i>C</i>. <i>albicans</i>. by Andrew S. Wagner (11331477)

Subjects:

Crz1 mediates masking in response to exogenous calcium. by Andrew S. Wagner (11331477)

Subjects:

Summary of measured parameters. by Aaron L. Sayler (19797446)

Subjects:

Effect of <i>slc43a3</i> deletion on metabolic performance parameters in male and female WT and KO mice. by Aaron L. Sayler (19797446)

Subjects:

Raw data. by Aaron L. Sayler (19797446)

Subjects:

Calcineurin mediates hyperactive Ste11^{<i>ΔN467</i>}-induced and caspofungin-induced unmasking in <i>C</i>. <i>albicans</i>. by Andrew S. Wagner (11331477)

Subjects:

Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3‑Oxo-3,4-dihydro‑2<i>H</i>‑ben... by Shuhei Ikeda (2380180)

Subjects:

Gating strategy for yeast cell population of <i>C</i>. <i>albicans</i>. by Andrew S. Wagner (11331477)

Subjects:

Cyclophosphamide treatment globally diminishes immune cells at early timepoints. by Andrew S. Wagner (11331477)

Subjects:

Loss of <i>FGR41</i> induces changes in total chitin and mannan levels in <i>C</i>. <i>albicans</i>. by Andrew S. Wagner (11331477)

Subjects:

Budget impact of prophylactic treatment of rVIII-SingleChain in moderate and severe hemophilia A in Italy by Eugenio Di Brino (12790748)

“…<p>rVIII-SingleChain, a recombinant factor VIII (rFVIII), has demonstrated safety and efficacy in patients with hemophilia A in clinical trials and real-world evidence. …”

Splicing of <i>Kluyveromyces lactis RPL22</i> is subject to Rpl22-mediated inhibition in both <i>K</i>. <i>lactis</i> and <i>S</i>. <i>cerevisiae</i>. by Kateřina Abrhámová (4739808)

“…(C) The abundance of <i>KlRPL22</i> mRNA expressed from the <i>RPL22A</i> locus as in (B) is decreased by the overproduction of either Rpl22A or Rpl22B. …”

The order of C10-AMS addition affects its inhibitory efficacy on AasS activity. by Haomin Huang (6042116)

“…<p><b>A.</b> Cartoon model of two opposite conformational states for AasS catalysis. …”

Fasting breath H₂ and gut microbiota metabolic potential are associated with the response to a fermented milk product in irritable bowel syndrome by Boris Le Nevé (6555629)

“…No difference between FMP or control groups was found on GI symptoms or breath H₂ and CH₄ in the whole cohort. A <i>post-hoc</i> analysis in patients stratified according to their fasting H₂ levels showed that in high H₂ producers (fasting H₂ level≥10ppm, n = 35), FMP consumption reduced fasting H₂ levels (p = 0.003) and H₂ production during the challenge (p = 0.002) and tended to decrease GI discomfort (p = 0.05) vs. control product. …”